2021 ELSO Adult and Pediatric Anticoagulation Guidelines
- PMID: 35080509
- DOI: 10.1097/MAT.0000000000001652
2021 ELSO Adult and Pediatric Anticoagulation Guidelines
Abstract
These guidelines for adult and pediatric anticoagulation for extracorporeal membrane oxygenation are intended for educational use to build the knowledge of physicians and other health professionals in assessing the conditions and managing the treatment of patients undergoing ECLS / ECMO and describe what are believed to be useful and safe practice for extracorporeal life support (ECLS, ECMO) but these are not necessarily consensus recommendations. The aim of clinical guidelines are to help clinicians to make informed decisions about their patients. However, adherence to a guideline does not guarantee a successful outcome. Ultimately, healthcare professionals must make their own treatment decisions about care on a case-by-case basis, after consultation with their patients, using their clinical judgment, knowledge and expertise. These guidelines do not take the place of physicians' and other health professionals' judgment in diagnosing and treatment of particular patients. These guidelines are not intended to and should not be interpreted as setting a standard of care or be deemed inclusive of all proper methods of care nor exclusive of other methods of care reasonably directed to obtaining the same results. The ultimate judgment must be made by the physician and other health professionals and the patient in light of all the circumstances presented by the individual patient, and the known variability and biological behavior of the clinical condition. These guidelines reflect the data at the time the guidelines were prepared; the results of subsequent studies or other information may cause revisions to the recommendations in these guidelines to be prudent to reflect new data, but ELSO is under no obligation to provide updates. In no event will ELSO be liable for any decision made or action taken in reliance upon the information provided through these guidelines.
Copyright © ELSO 2022.
Conflict of interest statement
Disclosure: The authors have no conflicts of interest to report.
Comment in
-
Forget-Me-Not: The Primary Hemostasis Defect in Extracorporeal Membrane Oxygenation May Require Unique Treatment.ASAIO J. 2023 Jan 1;69(1):e52. doi: 10.1097/MAT.0000000000001745. Epub 2022 Apr 18. ASAIO J. 2023. PMID: 35439191 No abstract available.
-
More to Learn About Acquired Von Willebrand Syndrome.ASAIO J. 2023 Jan 1;69(1):e53. doi: 10.1097/MAT.0000000000001744. Epub 2022 May 19. ASAIO J. 2023. PMID: 35593748 No abstract available.
-
Anticoagulation on Extracorporeal Support: An Alternative Strategy.ASAIO J. 2023 Mar 1;69(3):e131. doi: 10.1097/MAT.0000000000001786. Epub 2022 Jul 7. ASAIO J. 2023. PMID: 35801983 No abstract available.
References
-
- Saini A, Spinella PC: Management of anticoagulation and hemostasis for pediatric extracorporeal membrane oxygenation. Clin Lab Med. 34: 655–673, 2014.
-
- Esper SA, Welsby IJ, Subramaniam K, et al.: Adult extracorporeal membrane oxygenation: An international survey of transfusion and anticoagulation techniques. Vox Sang. 112: 443–452, 2017.
-
- Ozment CP, Scott BL, Bembea MM, Spinella PC; Pediatric ECMO (PediECMO) subgroup of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network and the Extracorporeal Life Support Organization (ELSO): Anticoagulation and transfusion management during neonatal and pediatric extracorporeal membrane oxygenation: A survey of medical directors in the United States. Pediatr Crit Care Med. 22: 530–541, 2021.
-
- Hirsh J, Raschke R, Warkentin TE, Dalen JE, Deykin D, Poller L: Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest. 102(Suppl 4): 337s–351s, 1992.
-
- McDonald MM, Jacobson LJ, Hay WW Jr, Hathaway WE: Heparin clearance in the newborn. Pediatr Res. 15: 1015–1018, 1981.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
